(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1630964

顧みられない熱帯病診断の市場規模、シェア、動向分析レポート：疾患別、診断方法別、サービスタイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease (Dengue, Chikungunya, Rabies, Leprosy), By Diagnostic Method, By Service Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
顧みられない熱帯病診断の市場規模、シェア、動向分析レポート：疾患別、診断方法別、サービスタイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年12月04日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

顧みられない熱帯病診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の顧みられない熱帯病診断の市場規模は、2030年までに95億9,000万米ドルに達すると予測されています。

同市場は2025年から2030年にかけてCAGR7.73％で成長すると予測されています。疾病負担の増加、疾病の早期発見に対する需要の高まり、技術の補完的進歩が需要の伸びを促進すると予測されます。

顧みられない熱帯病に対する関心の高まりと、それが人口だけでなく経済諸国に与える影響が、早期疾病検出法の開発需要を押し上げています。このような関心の高まりは、NTDsとの闘いを目的とした多くのプログラムの立ち上げにも表れています。例えば、顧みられない熱帯病のための世界ネットワークは、最も一般的なNTDsの制圧と撲滅に不可欠な意識向上と資金調達を目指しています。さらに、様々な企業が、より複雑で安価な熱帯病診断法の開発に取り組んでいます。2021年1月、Novartis AGはWHOと、ハンセン病を全世界で管理する契約を締結しました。このことは、予測期間を通じてこの市場の成長を支えるものと予想されます。

WHOによると、2022年1月現在、世界中で15億人以上が土壌伝染蠕虫感染症に感染しています。Kato-Katz technique法はWHOのゴールドスタンダードであり、STHsの強度を診断するために広く使用されています。これらの感染症は熱帯・亜熱帯地域に広く分布しており、アメリカ、サハラ以南のアフリカ、東アジア、中国で多く発生しています。さらに、主要企業の存在が市場全体の成長を促進すると予想されます。これらの企業が新製品開発に関与していることが、NTD診断市場の開拓に寄与していると考えられています。

顧みられない熱帯病診断市場のレポートハイライト

  • 疾患タイプ別では、土壌伝染性蠕虫病が、有病率の増加と診断検査の採用率の高さにより、2024年の市場を独占しました。
  • 2024年の市場規模は、分子/現代診断分野が圧倒的でした。これは、分子診断技術の研究開発促進とポイントオブケア製品の需要増によるものです。
  • 集中型サービスは、手技量が多く、インフラやマンパワーの面で補助的なサポートが広く存在するため、2024年の市場シェアで最大セグメントを占めました。
  • 最終用途別では、POCTサービスの人気と需要が高まっていることから、在宅ヘルスケアが最も急成長する見込みです。
  • アジア太平洋は2024年に世界市場を独占しましたが、これはNTDsの疾病負担の大きさ、ヘルスケア支出の増加、急速な技術進歩、NTDsの診断におけるPCR検査の使用に関する顧客の意識の高まりによるものです。
  • ラテンアメリカは、IVD製品の普及が進み、発展途上諸国におけるNTDsの疾病負担が大きいため、将来的に大きく成長すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 顧みられない熱帯病診断市場の変数、動向、範囲

  • 市場系統の見通し
    • 関連 / 付随市場の見通し
  • 浸透と成長の見込みマッピング
  • ユーザーの視点分析
    • 消費者行動分析
    • 市場インフルエンサー分析
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 業界の課題
  • 顧みられない熱帯病診断：市場分析ツール
    • 業界分析 - ポーターのファイブフォース分析
    • PESTEL分析

第4章 顧みられない熱帯病診断市場：セグメント分析、疾患別、2018年～2030年（百万米ドル）

  • 定義と範囲
  • 疾患市場シェア分析、2024年・2030年
  • 世界の顧みられない熱帯病診断市場、疾患別、2018年～2030年
  • 市場規模・予測と動向分析、2018年～2030年

第5章 顧みられない熱帯病診断市場：セグメント分析、診断方法別、2018年～2030年（百万米ドル）

  • 定義と範囲
  • 診断方法市場シェア分析、2024年・2030年
  • 世界の顧みられない熱帯病診断市場、診断方法別、2018年～2030年
  • 市場規模・予測と動向分析、2018年～2030年

第6章 顧みられない熱帯病診断市場：セグメント分析、サービスタイプ別、2018年～2030年（百万米ドル）

  • 定義と範囲
  • サービスタイプ市場シェア分析、2024年・2030年
  • 世界の顧みられない熱帯病診断市場、サービスタイプ別、2018年～2030年
  • 市場規模・予測と動向分析、2018年～2030年

第7章 顧みられない熱帯病診断市場：セグメント分析、最終用途別、2018年～2030年（百万米ドル）

  • 定義と範囲
  • 最終用途市場シェア分析、2024年・2030年
  • 世界の顧みられない熱帯病診断市場、最終用途別、2018年～2030年
  • 市場規模・予測と動向分析、2018年～2030年

第8章 顧みられない熱帯病診断市場：地域別市場分析、2018年～2030年（百万米ドル）

  • 定義と範囲
  • 地域別市場シェア分析、2024年・2030年
  • 地域市場ダッシュボード
  • 地域市場：主要企業
  • 市場規模、予測、動向分析、2018年～2030年：
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 顧みられない熱帯病診断市場 - 競合分析

  • 企業 / 競合の分類（主要なイノベーター、市場リーダー、新興企業）
  • ベンダー情勢
    • 主要販売代理店とチャネルパートナーのリスト
  • 主要企業プロファイル
    • F. Hoffmann-La Roche Ltd
    • Abbott
    • Thermo Fisher Scientific Inc.
    • ZeptoMetrix
    • InBios International, Inc.
    • Genome Diagnostics Pvt. Ltd.
    • Omega Diagnostics Group PLC
    • Coris BioConcept
    • DiaSys Diagnostic Systems GmbH
    • Oscar Medicare Pvt Ltd
図表

List of Tables

  • Table 1 Global Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 2 Global Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 3 Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 4 Global Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 5 North America Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 North America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 7 North America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 8 North America Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 10 U.S. Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 12 Canada Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 13 Canada Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 15 Europe Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 17 Europe Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 18 Europe Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 19 UK Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 20 UK Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 21 UK Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 22 Germany Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 23 Germany Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 25 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 26 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 27 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 29 Indonesia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 30 Indonesia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 31 Indonesia Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 32 China Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 33 China Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 34 China Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 35 India Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 36 India Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 37 India Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 38 Malaysia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 39 Malaysia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 40 Malaysia Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 41 Latin America Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 42 Latin America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 43 Latin America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 44 Latin America Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 45 Brazil Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 46 Brazil Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 47 Brazil Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 48 Colombia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 49 Colombia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 50 Colombia Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 51 Venezuela Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 52 Venezuela Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 53 Venezuela Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 58 Nigeria Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 59 Nigeria Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 60 Nigeria Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Neglected Tropical Diseases Diagnosis market segmentation
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 Market challenge relevance analysis (Current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration vs growth prospect mapping
  • Fig. 15 Neglected tropical diseases diagnosis market: Disease movement analysis
  • Fig. 16 Neglected tropical diseases diagnosis market: Diagnostic method movement analysis
  • Fig. 17 Neglected tropical diseases diagnosis market: Service type movement analysis
  • Fig. 18 Neglected tropical diseases diagnosis market: End use movement analysis
  • Fig. 19 Regional marketplace: Key takeaways
  • Fig. 20 Regional outlook, 2024 & 2030
  • Fig. 21 North America Neglected Tropical Diseases Diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 23 Canada neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 24 Europe neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 25 UK neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 26 Germany neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 27 Asia Pacific neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 28 Indonesia neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 29 China neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 30 India neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 31 Malaysia neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 32 Latin America neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 33 Brazil neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 34 Colombia neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 35 Venezuela neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 36 MEA neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 37 Nigeria neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-319-5

Neglected Tropical Diseases Diagnosis Market Growth & Trends:

The global neglected tropical diseases diagnosis market size is anticipated to reach USD 9.59 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 7.73% from 2025 to 2030. Increasing disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand.

Increasing concern regarding neglected tropical diseases and their impact on the population as well as economies has boosted the demand for the development of early disease detection methods. This growth in concern is evident in the launch of a substantial number of programs aiming to combat NTDs. For instance, the Global Network for Neglected Tropical Diseases aims to raise awareness and funding, both of which are essential to control and eliminate the most common NTDs. In addition, various companies are undertaking efforts to develop less complicated and inexpensive diagnostic assays for tropical diseases. In January 2021, Novartis AG signed an agreement with the WHO to manage leprosy across the globe. This, in turn, is anticipated to support the growth of this market throughout the forecast period.

According to the WHO, as of January 2022, more than 1.5 billion people are infected with soil-transmitted helminth infections worldwide. The Kato-Katz technique is the WHO gold standard that is widely used to diagnose the intensity of STHs. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China. Furthermore, the presence of key players is expected to fuel the overall market growth. The involvement of these players in new product development is considered to be the contributing factor to the development of the NTD diagnosis market.

Neglected Tropical Diseases Diagnosis Market Report Highlights:

  • By disease type, the soil-transmitted helminthiases dominated the market in 2024, owing to the increasing prevalence and high adoption of diagnostics tests
  • The molecular/modern diagnostic segment dominated the market in 2024, owing to an increase in R&D for molecular diagnostic techniques coupled with a rise in demand for point-of-care products
  • Centralized service accounted for the largest segment in terms of market share in 2024 due to high procedure volume and the wide presence of ancillary support in terms of infrastructure and manpower
  • By end-use, home healthcare is expected to be the fastest-growing segment as a result of the growing popularity and demand for POCT services
  • Asia Pacific dominated the global market in 2024, owing to the high disease burden of NTDs, increased healthcare expenditure, rapid technological advancements, and a rise in customer awareness about the use of PCR tests in diagnosing NTDs
  • Latin America is expected to grow considerably in the future, owing to increased IVD product penetration and the high disease burden of NTDs in developing countries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Information procurement
    • 1.2.1. Purchased database
    • 1.2.2. GVR's internal database
    • 1.2.3. Secondary sources & third-party perspectives
    • 1.2.4. Primary research
  • 1.3. Information analysis
    • 1.3.1. Data analysis models
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neglected Tropical Diseases Diagnosis Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. User perspective analysis
    • 3.3.1. Consumer Behavior Analysis
    • 3.3.2. Market Influencer Analysis
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Industry Challenges
  • 3.5. Neglected Tropical Diseases Diagnosis: Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier Power
      • 3.5.1.2. Buyer Power
      • 3.5.1.3. Substitution Threat
      • 3.5.1.4. Threat from new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political Landscape
      • 3.5.2.2. Environmental Landscape
      • 3.5.2.3. Social Landscape
      • 3.5.2.4. Technology Landscape
      • 3.5.2.5. Legal Landscape

Chapter 4. Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Disease, 2018 - 2030 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Disease market share analysis, 2024 & 2030
  • 4.3. Global Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 to 2030
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Dengue
    • 4.4.2. Chikungunya
    • 4.4.3. Rabies
    • 4.4.4. Leprosy
    • 4.4.5. Buruli ulcer
    • 4.4.6. Yaws
    • 4.4.7. Lymphatic Filariasis
    • 4.4.8. Taeniasis/Cysticercosis
    • 4.4.9. Foodborne trematode infections
    • 4.4.10. Echinococcosis
    • 4.4.11. Chagas disease
    • 4.4.12. Dracunculiasis
    • 4.4.13. Human African trypanosomiasis (sleeping sickness)
    • 4.4.14. Soil-transmitted helminthiases
    • 4.4.15. Onchocerciasis
    • 4.4.16. Schistosomiasis
    • 4.4.17. Scabies and other ectoparasites
    • 4.4.18. Snakebite Envenoming
    • 4.4.19. Leishmaniases

Chapter 5. Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Diagnostic Method, 2018-2030 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Diagnostic method market share analysis, 2024 & 2030
  • 5.3. Global Neglected Tropical Diseases Diagnosis Market, By Diagnostic method, 2018 to 2030
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Conventional Method
    • 5.4.2. Molecular/Modern Method

Chapter 6. Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Service Type, 2018 - 2030 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Service type market share analysis, 2024 & 2030
  • 6.3. Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 to 2030
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Centralized Service
    • 6.4.2. POC Service

Chapter 7. Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 7.1. Definitions & Scope
  • 7.2. End use market share analysis, 2024 & 2030
  • 7.3. Global Neglected Tropical Diseases Diagnosis Market, By End Use, 2018 to 2030
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Clinical Labs
    • 7.4.2. Hospitals /Clinics
    • 7.4.3. Home Healthcare

Chapter 8. Neglected Tropical Diseases Diagnosis Market: Regional Market Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1. Definitions & Scope
  • 8.2. Regional market share analysis, 2024 & 2030
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market: Key Players
  • 8.5. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030:
  • 8.6. North America
    • 8.6.1. North America market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2. U.S.
      • 8.6.2.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3. Canada
      • 8.6.3.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7. Europe
    • 8.7.1. Europe market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.2. Germany
      • 8.7.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3. UK
      • 8.7.3.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.8. Asia Pacific
    • 8.8.1. Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.2. China
      • 8.8.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.3. Indonesia
      • 8.8.3.1. Indonesia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.4. India
      • 8.8.4.1. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.5. Malaysia
      • 8.8.5.1. Malaysia market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.9. Latin America
    • 8.9.1. Latin America market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.2. Brazil
      • 8.9.2.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.3. Colombia
      • 8.9.3.1. Colombia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.4. Venezuela
      • 8.9.4.1. Venezuela market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.10. Middle East and Africa
    • 8.10.1. Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.10.2. Nigeria
      • 8.10.2.1. Nigeria market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Neglected Tropical Diseases Diagnosis Market - Competitive Analysis

  • 9.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 9.2. Vendor Landscape
    • 9.2.1. List of key distributors and channel partners
  • 9.3. Key companies profiled
    • 9.3.1. F. Hoffmann-La Roche Ltd
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Abbott
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Thermo Fisher Scientific Inc.
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. ZeptoMetrix
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. InBios International, Inc.
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Genome Diagnostics Pvt. Ltd.
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Omega Diagnostics Group PLC
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Coris BioConcept
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. DiaSys Diagnostic Systems GmbH
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Oscar Medicare Pvt Ltd.
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives